Circadian rhythm of lipoprotein subfractions
Not Applicable
- Conditions
- dyslipidemia
- Registration Number
- JPRN-UMIN000033535
- Lead Sponsor
- Tokyo Medical and Dental University (TMDU)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with diabetes using insulin Those who are not permitted for participation by their physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Circadian rhythm of lipoprotein subfractions could be found
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie lipoprotein subfraction variations in dyslipidemia patients during circadian cycles?
How does circadian rhythm affect the efficacy of lipid-lowering therapies compared to standard-of-care treatments in dyslipidemia?
Which biomarkers correlate with lipoprotein subfraction dynamics in circadian rhythm studies for dyslipidemia management?
What adverse events are associated with circadian-based lipid monitoring and how are they managed in dyslipidemia research?
Are there combination therapies involving PCSK9 inhibitors or statins that align with circadian lipoprotein patterns in dyslipidemia?